Serono has held talks with four leading drugmakers about a potential $15 billion takeover in recent weeks, the Wall Street Journal said on Wednesday, citing people familiar with the matter. Amgen Inc. said on Tuesday that Swiss-based Serono SA, which has hired bankers to explore deals for the company, would not be a good fit for the world’s biggest biotechnology company.
